HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of brain-derived neurotrophic factor among subtypes of exudative age-related macular degeneration.

AbstractPURPOSE:
To compare the levels of brain-derived neurotrophic factor (BDNF) in serum and aqueous humor (AH) in eyes with typical neovascular age-related macular degeneration (tAMD), polypoidal choroidal vasculopathy (PCV), and retinal angiomatous proliferation (RAP).
METHODS:
This prospective study included 20 patients with tAMD, 20 patients with PCV, 20 patients with RAP, and 20 healthy controls. BDNF levels in the serum and AH were assessed using enzyme-linked immunosorbent assay.
RESULTS:
Serum and AH BDNF levels were significantly lower in the age-related macular degeneration groups (tAMD, PCV, and RAP) than in the control group (p < 0.05). There was no significant difference in the mean BDNF levels in the serum and AH among the different nAMD subtypes (p = 0.538).
CONCLUSIONS:
We confirmed that serum and AH BDNF levels were independent of the nAMD subtype.
AuthorsKeon Woo Park, Jung Yeon Joo, Seong Taeck Kim
JournalEuropean journal of ophthalmology (Eur J Ophthalmol) Vol. 33 Issue 1 Pg. 408-414 (Jan 2023) ISSN: 1724-6016 [Electronic] United States
PMID35505604 (Publication Type: Journal Article)
Chemical References
  • Brain-Derived Neurotrophic Factor
Topics
  • Humans
  • Brain-Derived Neurotrophic Factor
  • Prospective Studies
  • Macular Degeneration
  • Wet Macular Degeneration (diagnosis)
  • Fluorescein Angiography
  • Choroid
  • Choroidal Neovascularization

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: